Skip to main content
Caplight Logo









Ascilion AB

Ascilion AB

Private
KistaHealthcare & Life Scienceshttps://www.ascilion.com/

Last Round

Series A

Sep 22, 2025

Total Funding Raised

$2.85M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ascilion AB is a medtech company that has developed a microneedle technology platform for the painless extraction of dermal interstitial fluid for diagnostics and health monitoring.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Sensors, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Infrastructure

Keywords

dISF samplinghollow microneedlesminimally invasive samplingmicroneedle technologymicroneedle patchbiomarker monitoringdermal interstitial fluidbiomarker accesspainless samplingliquid biopsywearable sensorsblood draw alternativedrug development toolsbiosensor platformcosmetic testingclinical trial toolsMEMS manufacturingprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ascilion AB Comparables

Compare Ascilion AB with similar companies based on industry and business-model similarity.

Ascilion AB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DermiSense, Inc.
78%
Micropoint Technologies
77%
Xsensio
74%

Ascilion AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 22, 2025
SeedJan 3, 2022
GrantJan 1, 2021

Key People

Founding team and executive leadership

Pelle Rangsten

Co-founder & CTO

Founding Team

Ascilion AB Investors

Notable investors and investment history

Ascilion AB investors
InvestorRounds
NordstjernanSeed
European CommissionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2026

    Grew 30% QoQ, from 10 to 13 employees.

  • Feb 25, 2026

    Grew 83% QoQ from 6 to 11 employees.

Ascilion AB Filings

Explore SEC and related filing metadata, where available.

Ascilion AB filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ascilion AB's valuation, stock price, and market status.

Is Ascilion AB a public or private company?

Ascilion AB is a private company.

What is the current stock price of Ascilion AB?

Ascilion AB is a private company with no public stock price. No recent secondary market data is available.

How much is Ascilion AB worth (valuation)?

Valuation information for Ascilion AB is not publicly available.

Can I buy Ascilion AB stock?

Ascilion AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ascilion AB's last funding round?

Funding round information for Ascilion AB is not publicly available.

Who are the main investors in Ascilion AB?

Investor information for Ascilion AB is not publicly disclosed.

Will Ascilion AB IPO soon?

No public IPO plans have been announced for Ascilion AB.

How can I track Ascilion AB secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ascilion AB's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersKista
Employee Range13
Year Founded2012
Last FundingSep 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?